These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2170841)

  • 1. Somatostatin-receptor imaging for the detection of tumors.
    Patel YC
    N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
    Schubert ML
    Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin-receptor imaging in the localization of endocrine tumors.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new imaging procedure for detecting endocrine tumors].
    Schäffer M; Fölsch UR
    Z Gastroenterol; 1991 Apr; 29(4):173-4. PubMed ID: 1651031
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
    Lamberts SW; Reubi JC; Krenning EP
    Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
    Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
    van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
    World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.
    Kvols LK; Brown ML; O'Connor MK; Hung JC; Hayostek RJ; Reubi JC; Lamberts SW
    Radiology; 1993 Apr; 187(1):129-33. PubMed ID: 8383865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new diagnostic method: somatostatin receptor scintigraphy of neuroendocrine tumors].
    Westlin JE; Janson ET; Ahlström H; Ohrvall U; Arnberg H; Nilsson S; Akerström G; Oberg K
    Lakartidningen; 1992 Dec; 89(50):4377-9. PubMed ID: 1469974
    [No Abstract]   [Full Text] [Related]  

  • 12. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat.
    Bruns C; Stolz B; Albert R; Marbach P; Pless J
    Horm Metab Res Suppl; 1993; 27():5-11. PubMed ID: 8392488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
    Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
    J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
    Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
    Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
    Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
    J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
    Virgolini I; Traub-Weidinger T; Decristoforo C
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):213-27. PubMed ID: 15763696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
    Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
    J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.